PSG and Neuroendocrine Hormones in Subjective Cognitive Impaired Patients With Transformed Migraine

CompletedOBSERVATIONAL
Enrollment

161

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

March 1, 2020

Study Completion Date

April 1, 2020

Conditions
Migraine
Interventions
DEVICE

Polysomnography

PSG was carried out for 41 patients with subjective cognitive impairment and 41 age and sex-matched controls. PSG with standard EEG montage that includes bilateral EOG and four EEG leads were used. A single attended overnight PSG study was performed at the Clinical Neurophysiology Unit of Mansoura University Hospitals. Patients were studied in a quiet, darkened room with no medications were used to induce sleep. All participants underwent one night of laboratory-based PSG.

Trial Locations (1)

35516

Mansoura University Hospital, Al Mansurah

All Listed Sponsors
lead

Mansoura University Hospital

OTHER

NCT04413110 - PSG and Neuroendocrine Hormones in Subjective Cognitive Impaired Patients With Transformed Migraine | Biotech Hunter | Biotech Hunter